|

Sacubitril / Valsartan Oral Tablet [Entresto] Clinical Trials

2 actively recruiting trials

Also known as: Angiotensin receptor-neprilisin inhibitor (ARNI)

Pipeline

Phase 3: 1

Top Sponsors

  • University of Sao Paulo General Hospital1
  • Beijing Friendship Hospital1

Indications

  • Heart Disease2
  • Chagas Cardiomyopathy1
  • Sacubitril/Valsartan1
  • Hypertension1
  • Obesity1

Other2 trials

Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.
Phase 3
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.